Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 9/20 | 0.43 |
| ▸ | CNR1 | P21554 | 5/20 | 0.40 |
| ▸ | TNNC1 | P63316 | 5/20 | 0.39 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.39 |
| ▸ | SGPL1 | O95470 | 1/20 | 0.39 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.39 |
| ▸ | GPR183 | P32249 | 1/20 | 0.39 |
| ▸ | CERS2 | Q96G23 | 1/20 | 0.39 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.39 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.39 |
| ▸ | STS | P08842 | 1/20 | 0.38 |
| ▸ | LPL | P06858 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
| ▸ | SPNS2 | Q8IVW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14390805 | 0.91 | CNR2 (0.48) | CNR2CNR1TNNC1S1PR1SGPL1 | |
| SCHEMBL14419136 | 0.91 | CNR2 (0.48) | CNR2CNR1TNNC1S1PR1SGPL1 | |
| SCHEMBL18531364 | 0.84 | CA2 (0.41) | CNR2TNNC1S1PR1SGPL1S1PR4 | |
| SCHEMBL13354844 | 0.84 | CA2 (0.41) | CNR2TNNC1S1PR1SGPL1S1PR4 | |
| SCHEMBL13425909 | 0.83 | CA2 (0.43) | CNR2TNNC1S1PR1SGPL1S1PR4 | |
| SCHEMBL1128467 | 0.82 | SHBG (0.42) | HTR2A | |
| SCHEMBL1128006 | 0.81 | HTR2A (0.69) | HTR2ATNNC1S1PR1SGPL1S1PR4 | |
| SCHEMBL4581334 | 0.80 | CNR2 (0.56) | CNR2CNR1 | |
| SCHEMBL14228174 | 0.79 | CNR2 (0.46) | CNR2LPLLIPG | |
| SCHEMBL13434787 | 0.79 | KCNH2 (0.47) | CNR2STSLPLLIPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140034623-A1 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | BASF SE (DE) | 2014-02-06 | — | — | US | disclosed |
| EP-2283021-B1 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | BASF SE (DE) | 2014-01-08 | — | — | EP | disclosed |
| US-8586745-B2 | Switchable special effect substances | BASF SE (DE) | 2013-11-19 | — | — | US | disclosed |
| US-20110060113-A1 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | BASF SE (DE) | 2011-03-10 | — | — | US | disclosed |
| EP-2283021-A2 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | BASF SE (DE) | 2011-02-16 | — | — | EP | disclosed |
| WO-2009141288-A2 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | BASF SE (DE) | 2009-11-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110060113-A1 | SWITCHABLE SPECIAL EFFECT SUBSTANCES | PPARG, PTGER4, NR2E3 | HTR2A 2693/4885CNR2 4051/4885CNR1 4357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.